Trial Profile
Umbilical Cord Blood-derived Mesenchymal Stem Cells for the Treatment of Steroid-refractory Acute or Chronic Graft-versus-host-disease
Status:
Recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 21 Jul 2022
Price :
$35
*
At a glance
- Drugs Mesenchymal stem cell therapy (Primary)
- Indications Graft-versus-host disease
- Focus Adverse reactions
- Acronyms GVHD-MSC
- 22 Dec 2015 New trial record